metformin vs glp-1 GLP-1s lower death risk in adults with type 2 diabetes, cancer Exploratory real-world experience with GLP-1

Pre-existing neuropathy The case of the 75-year-old man with baseline neuropathy who developed severe allodynia on tirzepatide suggests that pre-existing nerve damage may create vulnerability

According to WHO and other researchers, if nothing is done to curb the problem, the global cost of overweight and obesity could potentially reach US$3 trillion per year by 2030 and more than US$18 trillion by 2060 (WHO 2024

The market had changed enough by the time the institute revisited the topic in 2025 and found some drugs cost-effective at certain prices and formulations

Orlistat is a lipase inhibitor

The Exendin-4 (Ex4) is a 39 amino acid peptide agonist of the GLP-1 receptor